skip to primary navigationskip to content

Cambridge Institute for Medical Research

Department A-Z

Our strategy

We aim to create an inspiring environment in which outstanding scientists can excel. By providing state-of-the-art core facilities and support for our researchers, we foster new collaborations that spark discoveries about fundamental cellular processes and their relevance in disease.

Read more

Cambridge Science Festival

Learn about CIMR research with hands-on activities and microscopy movies at the Corn Exchange (March 14 and 15) and the Biomedical Campus (March 22).

Read more

Research advances

In collaboration with Microsoft Research and the Dept of Biochemistry, the Göttgens lab show in Nature Biotechnology that single-cell analysis can be coupled with computational modelling to reveal the transcriptional networks driving blood cell development.

Read more

Research advances

The Rubinsztein lab report in Molecular Cell that phosphatidylinositol 5-phosphate (PI(5)P) promotes autophagosome biogenesis and that it can sustain autophagy when PI(3)P is depleted. This highlights a novel cytoplasmic role for PI(5)P as a regulator of non-canonical autophagy.

Read more

Cambridge Drug Discovery Institute

Alzheimer's Research UK has announced an £30m Drug Discovery Alliance, which will include a new institute on the Cambridge Biomedical Campus with CIMR Deputy Director David Rubinsztein as its academic lead. Its primary focus will be on the development of new treatments for Alzheimer's and other causes of dementia.

Read more

News

Andres Floto discusses in Cambridge News how altering the innate immune system response during infection may help provide improved treatments for conditions such as tuberculosis and cystic fibrosis.

Read more

News

In an interview with Cambridge News, David Rubinsztein outlines research efforts to target the autophagy process as a means of delaying the onset of neurodegenerative disease.

Read more

EMBO interview

David Ron reviews his career choices in the autumn issue of EMBOencounters, as well as his election to the Royal Society and the importance of sustaining public support for science.

Read more

Wellcome-Beit Prize Fellowship

Congratulations to Eoin McKinney in the Smith lab, who has been awarded a Wellcome Trust Intermediate Clinical Fellowship and a Wellcome-Beit Prize Fellowship, the latter of which recognizes just four outstanding biomedical researchers each year.